Item 2.02 Results of Operations and Financial Condition. On May 26, 2026, Kailera Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
KLRA Kailera Therapeutics, Inc. - 8-K
Accession
0001193125-26-2393622.029.01
Item 2.02 - Results of Operations and Financial Condition
Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.
Item 9.01 - Financial Statements and Exhibits
31 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Earnings Press Release dated May 26, 2026. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)